Sun Life to proactively offer second opinions on cancer diagnoses when members file a cancer-related claim
MWN-AI** Summary
Sun Life U.S. is enhancing its member services by proactively offering Expert Cancer Review (ECR) second opinions to those who file cancer-related claims for disability or critical illness insurance. This initiative is designed to bolster member confidence in their treatment plans by connecting them with independent oncology specialists who can provide objective assessments of their diagnoses.
Beginning in 2024, members enrolled in Sun Life's disability or supplemental benefits will receive outreach upon filing cancer claims, ensuring timely access to ECR services available through their employer’s stop-loss policy. This approach aims to assist members as soon as possible after diagnosis, thus potentially leading to different treatment paths or confirming existing plans. Data from 2024-2025 highlighted that 41% of second opinions led to revisions in diagnosis or treatment strategy.
Sun Life recognizes that cancer remains one of the costliest diseases to manage in the U.S., with annual claims averaging $235,000 to over $300,000. By facilitating early second opinions, Sun Life aims to prevent misdiagnoses and reduce unnecessary treatments, ultimately enhancing care while aligning with employers' interests in maintaining workforce health and productivity.
As cancer diagnoses rise among younger individuals, particularly those under 50, proactive engagement through ECR can play a critical role in navigating treatment pathways. Sun Life's integrated Health and Risk Solutions, including personal health advisors and automatic screening for critical illness benefits, reflect the company's commitment to comprehensive support for its members facing cancer.
This initiative not only enriches the member experience but also supports employers by potentially improving health outcomes and managing costs effectively, all while reinforcing Sun Life's role as a prominent player in providing employee benefits solutions.
MWN-AI** Analysis
Sun Life’s recent initiative to offer proactive Expert Cancer Reviews (ECR) when members file cancer-related claims presents a significant opportunity in the health benefits market. By connecting members with independent oncology specialists, Sun Life aims to enhance patients’ confidence in their treatment plans and ultimately improve health outcomes. With the continuing rise in cancer diagnoses, particularly among individuals under 50, this strategy could help mitigate misdiagnoses and optimize treatment paths, presenting a compelling case for both members and employers.
For financial analysts and investors, it’s important to recognize that this initiative aligns with trends emphasizing quality care and cost efficiency. Cancer care is notably expensive, with average claims reaching $235,000 to $300,000 depending on the cancer type. ECR services can potentially reduce unnecessary treatments, leading to lower costs in the long run for Sun Life's stop-loss insurance and disability claims, making them an attractive option for employers seeking to control healthcare costs while supporting their employees.
Additionally, Sun Life is integrating ECR with its existing health navigator services, enhancing their overall value proposition, which can appeal to a broader client base as employers increasingly prioritize comprehensive employee health support.
Investors should consider how this initiative positions Sun Life relative to its competitors in the employee benefits marketplace. By proactively engaging members at critical moments, Sun Life is likely to enhance customer loyalty and retention. This focus on member-centric care will not only distinguish Sun Life but could also bolster its financial performance over time by tapping into the increasing demand for effective health solutions.
Overall, stakeholders should monitor the evolution of this strategy, particularly its impact on claim outcomes and customer satisfaction, as these metrics will ultimately reflect its success and influence Sun Life’s market position.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Expert Cancer Review services help boost members' confidence in their cancer treatment plan
WELLESLEY, Mass., Feb. 23, 2026 /PRNewswire/ -- Sun Life U.S. is expanding access to its Expert Cancer Review (ECR) service by proactively engaging members closer to the time of diagnosis. When a member files a cancer-related claim for disability or critical illness/cancer (supplemental health) insurance, Sun Life will reach out to connect them to ECR services available through their employers' Sun Life stop-loss policy. Members must also be enrolled in Sun Life disability or supplemental benefits.
ECR provides members diagnosed with cancer an objective, documented second opinion from an independent oncology specialist, helping to ensure they get the right care and feel confident in their chosen treatment plan. From 2024 – 2025, 41% of the second opinions facilitated by Sun Life resulted in a change in diagnosis or shift in diagnostic strategy or treatment.
"Offering a second opinion when our members file a cancer-related claim for disability or critical illness/cancer benefits enables us to support them closer to the time of their diagnosis," said Joi Tillman, president, Group Benefits, Sun Life U.S. "Expert Cancer Review will help members feel more confident in their treatment while their Sun Life disability and supplemental health plans replace their income and pay cash benefits to help them cover out-of-pocket costs. This is a great next step in integrating our Health and Risk Solutions services with our Group Benefits member experience, following the initial expansion of our Health Navigator personal care advisor services last year."
Cancer continues to be one of the most frequently diagnosed and costliest diseases to treat in the U.S. According to Sun Life's 2025 High Cost Claims Report, the average annual cost of a cancer claim ranged from about $235,000 for malignant neoplasm ("solid" cancers) to over $300,000 for leukemia, lymphoma, and multiple myeloma (blood cancers). While ECR is already available through an employer's Sun Life medical stop-loss policy, members can now receive proactive outreach when filing a cancer-related disability or supplemental health claim with Sun Life – engaging them earlier in the process, when the expert second opinion can be more valuable to the member.
According to the National Institute of Health, cancer diagnoses have become more prevalent in those under age 50 – people still in the workforce. Sun Life's High Cost Claims Report showed that solid cancers, particularly in adults ages 40-59, made up more than 40% of the total medical spend across Sun Life's stop-loss claims for 2024. As more people in the workforce encounter cancer diagnoses, employee benefits can play a pivotal role in increasing access to care and support.
"Expert second opinions on cancer can avoid misdiagnoses and spare people unnecessary treatments, as well as lead to better, more tailored therapies," said Jen Collier, president, Health and Risk Solutions, Sun Life U.S. "More efficient and effective care also drives down costs, which benefits both the member and their employer. Proactively connecting eligible members to ECR will support our employer clients as they help their employees stay at or return to work, and drive better health outcomes overall."
Sun Life has continuously evolved its approach to benefits integration to better support those with cancer. In addition to offering healthcare navigation and ECR, Sun Life automatically screens a member for critical illness/cancer benefits when there is a stop-loss (high-dollar) claim filed for cancer. If they are covered, the member receives their benefit payment without needing to file a separate claim.
ECR is facilitated by Sun Life Health Navigator, a service that provides personal health advisors who help people get the right care, doctors and treatment to support them through their medical journey. Second opinions are an integral part of Health Navigator services, whether for cancer or other diagnoses.
To learn more about impacts of cancer in the workforce and the support of Sun Life benefits, visit www.sunlife.com/cancer.
About Sun Life
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of December 31, 2025, Sun Life had total assets under management of C$1.6 trillion. For more information, please visit www.sunlife.com.
Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.
Sun Life U.S. is one of the largest providers of employee and government benefits, helping approximately 50 million Americans access the care and coverage they need. Through employers, industry partners and government programs, Sun Life U.S. offers a portfolio of benefits and services, including dental, vision, disability, absence management, life, supplemental health, medical stop-loss insurance, and healthcare navigation. Sun Life employs more than 8,300 people in the U.S., including associates in our partner dental practices and affiliated companies in asset management. Group insurance policies are issued by Sun Life Assurance Company of Canada (Wellesley Hills, Mass.), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.). For more information visit our website and newsroom.
Media contacts
Devon Fernald
Sun Life U.S.
Devon.Portney.Fernald@sunlife.com
781-800-3609
Connect with Sun Life U.S.
SOURCE Sun Life U.S.
FAQ**
How does Sun Life Financial Inc. SLF ensure the independence and expertise of the oncology specialists involved in the Expert Cancer Review process for members filing claims?
What measures does Sun Life Financial Inc. SLF take to educate members about the benefits of obtaining a second opinion on their cancer diagnosis and treatment options?
How does Sun Life Financial Inc. SLF track the outcomes of members who utilize the Expert Cancer Review service, and what data do they gather to evaluate its effectiveness?
In what ways does Sun Life Financial Inc. SLF integrate feedback from members who have accessed the Expert Cancer Review service to continuously improve their cancer support programs?
**MWN-AI FAQ is based on asking OpenAI questions about Sun Life Financial Inc. (TSXC: SLF:CC).
NASDAQ: SLF:CC
SLF:CC Trading
-0.54% G/L:
$58.52 Last:
2,093,240 Volume:
$58.84 Open:
